Event Details

Event: 1st Meeting of the Irish Institute for Metal-Based Drugs (IIMBD)

Date: September 20, 2007

Venue: Houston Theatre, RCSI



14:00 – 14:10 Opening of the Meeting
Prof. Kevin B. Nolan (RCSI)
14:10 – 14.40 Response of Candida albicans to silver-based antifungal drugs
Dr. Kevin Kavanagh and Dr. Malachy McCann (NUIM)
14.40 – 15.10 Novel metal-based coumarins – chemistry and anti-cancer activity
Dr. Denise Egan and Dr. Maureen Walsh (ITT)
15.10 – 15:35 Novel titanocene anticancer drugs
Dr. Matthias Tacke and Dr. William Watson (UCD)
15:35 – 16.00 Coffee Break
16.00 – 16.25 Reactions of the anticancer molybdocene dichloride with biomolecules
Dr. Andrea Erxleben (NUIG)

16:25 – 16:50
Palladium and platinum iminophosphines: potential anticancer agents
Dr. Orla Ni Dhubhghaill (UCC)
16:50 – 17.15 Pt- and Ru-hydroxamates: NO-donors and in vitro anti-tumour activity
Dr. Celine Marmion (RCSI)
17.15 – 17.45 Simple Copper Carboxylates: biomimetics with anticancer activity
Prof. Mick Devereux and Dr Denis O’Shea (DIT)
17:45 – 18:15 Round Table Discussion

Followed by a wine reception
All welcome to attend

Please confirm attendance with pwhyte@rcsi.ie

*The IIMBD was recently formed by researchers working in the area of metal-based drugs. The mission of IIMBD is to promote high quality research on metal-based therapies and to raise awareness of their potential benefits for society. IIMBD welcomes membership from researchers working in the area with a view to developing future collaborations and joint research applications.


More Events